IceCure Medical (NASDAQ:ICCM – Get Free Report) and Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.
Risk and Volatility
IceCure Medical has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.75, meaning that its share price is 375% more volatile than the S&P 500.
Insider & Institutional Ownership
0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 0.3% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| IceCure Medical | 0 | 0 | 2 | 0 | 3.00 |
| Intelligent Bio Solutions | 0 | 0 | 0 | 0 | N/A |
IceCure Medical presently has a consensus target price of $2.95, indicating a potential upside of 273.89%. Given IceCure Medical’s higher possible upside, analysts plainly believe IceCure Medical is more favorable than Intelligent Bio Solutions.
Profitability
This table compares IceCure Medical and Intelligent Bio Solutions’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IceCure Medical | -444.30% | -101.66% | -77.73% |
| Intelligent Bio Solutions | -354.86% | -210.36% | -89.33% |
Valuation and Earnings
This table compares IceCure Medical and Intelligent Bio Solutions’ gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| IceCure Medical | $3.26 million | 11.04 | -$14.65 million | ($0.33) | -2.39 |
| Intelligent Bio Solutions | $2.83 million | 2.08 | -$10.63 million | ($38.91) | -0.05 |
Intelligent Bio Solutions has lower revenue, but higher earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
Summary
IceCure Medical beats Intelligent Bio Solutions on 8 of the 13 factors compared between the two stocks.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
About Intelligent Bio Solutions
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.
